NASA's new rocket won't be ready for moon shot next year
NASA's massive new rocket won't be ready for a moon shot next year, the space agency's top official told Congress on Wednesday.
NASA's massive new rocket won't be ready for a moon shot next year, the space agency's top official told Congress on Wednesday.
Space Exploration
Mar 13, 2019
2
22
Biologists have long assumed that all jawed vertebrates possess a full complement of nearly identical genes for critical aspects of their development. But a paper in the December 16 issue of Science with Benjamin King of ...
Biotechnology
Dec 15, 2011
1
0
A pair of plant biologists at the Institute of Transformative Bio-Molecules (ITbM) of Nagoya University, has reported in the journal Plant and Cell Physiology, on the development of a new vector (a carrier to transfer genetic ...
Biotechnology
Dec 5, 2016
0
5
Nipponosaurus sachalinensis—a controversial hadrosaurid dinosaur whose fossilized skeleton was unearthed in southern Sakhalin in 1934—is found to be a valid taxon and a juvenile that had not reached sexual maturity.
Archaeology
Jun 9, 2017
0
47
A study published in the Journal of Medicinal Chemistry reports the discovery of a novel PHD inhibitor for the treatment of anemia.
Analytical Chemistry
Jan 19, 2024
0
83
A NASA spacecraft hurtling toward Mars prepared to fire its thrusters Wednesday to put itself on course for an August landing.
Space Exploration
Jan 11, 2012
0
0
NASA discovered a bevy of headaches in its first three tries to run through a dress rehearsal countdown of the Artemis I moon rocket at Kennedy Space Center earlier this year. Now it's ready for attempt No. 4.
Space Exploration
May 30, 2022
0
38
Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated ...
Bio & Medicine
Sep 13, 2022
0
155
There are currently few good treatment options for glioblastoma, an aggressive type of brain cancer with a high fatality rate. One reason that the disease is so difficult to treat is that most chemotherapy drugs can't penetrate ...
Bio & Medicine
Jun 2, 2022
0
78
Recent research has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.
Analytical Chemistry
Jan 19, 2024
0
37